Alcohol Measuring Device Face Verification Against Sample Manipulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing drug measuring devices, such as alcohol measuring devices, are vulnerable to manipulation during use, particularly in remote alcohol monitoring scenarios, where users may attempt to deceive the system by providing fake samples or using someone else's identity.
Innovation Solution
The implementation of an activation process and device that utilizes a reference image set for user verification, allowing the device to be released only if the user's face is correctly identified through image comparison, both during the activation phase and subsequent use phases, thereby ensuring that only the authorized user can operate the device and provide valid samples.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If a drug measuring device is made accessible for remote monitoring use, then the convenience and accessibility of the monitoring system is improved, but the vulnerability to manipulation and unauthorized use increases
Solution Approach 1:
The system performs preliminary verification actions before allowing device operation. During the activation phase, the user's face is captured and stored as reference data. Before each measurement, the system performs preliminary face recognition verification to ensure the authorized user is present, preventing manipulation before it can occur.
Solution Approach 2:
The system implements continuous feedback mechanisms through face recognition verification. The captured face image is compared against stored reference data, and the system provides feedback by either allowing or blocking measurement operations. This closed-loop verification ensures that only authorized users can operate the device, maintaining reliability while enabling remote access.
2Reliability
If face recognition verification is implemented during activation and use phases, then the security and reliability of the system is improved, but the device complexity and operational steps increase
Solution Approach 1:
The system creates a digital copy of the user's face during the activation phase and stores it as reference data. This copied facial information is then used for verification during the use phase, eliminating the need for complex real-time biometric analysis while maintaining reliable user identification through image comparison.
Solution Approach 2:
The complex verification setup is performed in advance during the activation phase, where reference face images are captured and stored. This preliminary action separates the complexity of setting up verification from the actual measurement process, making the device easier to use during routine operations while maintaining high security standards.
3Reliability
If image recording and comparison functionality is added to verify user identity, then the prevention of manipulation is improved, but the loss of time for activation and measurement increases
Solution Approach 1:
The system performs the time-consuming image capture and reference setup during the activation phase in advance. Once the reference facial image is stored, subsequent measurements only require rapid image comparison against this pre-established reference, significantly reducing the time required for actual measurements while maintaining manipulation prevention.
Solution Approach 2:
By creating and storing a reference copy of the user's face during activation, the system enables rapid verification during measurements. The comparison process is much faster than initial image capture and analysis, reducing the time penalty for verification while ensuring manipulation prevention through consistent reference matching.
Data Source
AI summary
A process and an activation device (30) provides a user (B) activation of a drug measuring device (100). This drug measuring device includes an input unit (3), a testing unit (6) for testing given samples and an image recording device (12). The activation device (30) receives an activation image set (InB), which was generated by the drug measuring device or by a drug measuring device and at least one image (40, 40.1) from the image recording device. The received activation image set is checked as to meeting a predefined release criterion. For this the activation image set is compared with a predefined reference image set (35) for the user. If the release criterion is met, the drug measuring device is released for the user. An activation data set (32) for the user is completed by at least one image of the activation image set, which shows the user.